NCT01236534View on ClinicalTrials.gov

Lubiprostone in Patients With Multiple Sclerosis Associated Constipation

PHASE4CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

April 30, 2012

Conditions

Multiple SclerosisConstipation

Interventions

DRUG

Lubiprostone

24 mcg twice daily for 21 days.

DRUG

Placebo

matching placebo twice daily for 21 days.

Trial Locations (1)

14642

University of Rochester, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Takeda

INDUSTRY

lead

University of Rochester

OTHER